Annual Report Details 2025 Financial Decline, Subsidiary Dilution, and Persistent Geopolitical Risks
Summary
ACM Research's 2025 annual report shows a drop in net income and negative operating cash flow, alongside a significant capital raise by its Shanghai subsidiary that diluted ownership, all within a complex and challenging U.S.-China regulatory environment.
Key Events
-
2025 Financial Performance Decline
Net income attributable to ACM Research, Inc. decreased to $94.078 million in 2025 from $103.627 million in 2024. Basic EPS fell to $1.47 from $1.67, and diluted EPS to $1.37 from $1.53. Operating activities resulted in a net cash outflow of $10.325 million in 2025, a significant reversal from the $152.450 million inflow in 2024, indicating operational challenges despite a 15.2% revenue increase to $901.309 million.
-
Significant Subsidiary Capital Raise and Ownership Dilution
In September 2025, ACM Research's Shanghai operating subsidiary completed a private offering, selling 38,601,326 ordinary shares for approximately $623.0 million in net proceeds. This transaction reduced ACM Research's ownership interest in ACM Shanghai from 81.5% to 74.6%.
-
Persistent Geopolitical and Regulatory Risks Detailed
The report extensively details ongoing risks from U.S.-China trade tensions, including the December 2, 2024, addition of ACM Shanghai and ACM Korea to the BIS Entity List, which restricts access to U.S. export-controlled hardware, software, and technologies. New U.S. Outbound Investment Security Program (OISP) regulations and the COINS Act are also discussed, potentially limiting cross-border investment opportunities, though the COINS Act is expected to reverse OISP application for ACM Research in 2026 or 2027.
-
Insider 10b5-1 Trading Plans Adopted
Three key individuals – Director Charles Pappis (10,000 shares), ACM Shanghai CFO Lisa Feng (30,000 shares), and Director Tracy Liu (60,000 shares) – adopted Rule 10b5-1 trading arrangements in late 2025 to sell Class A Common Stock starting in March 2026. These are pre-planned sales, but represent a notable aggregate volume of shares.
Analysis
This annual report provides a comprehensive overview of ACM Research's 2025 fiscal year, revealing a decline in net income and a shift to negative operating cash flow, despite overall revenue growth. A significant event was the private offering by its Shanghai subsidiary, which raised substantial capital but diluted ACM Research's ownership. The filing also reiterates and elaborates on the critical geopolitical risks, including the U.S. BIS Entity List designation for its key subsidiaries and the evolving U.S. outbound investment regulations, which pose ongoing challenges to its China-centric operations. The combination of declining profitability, negative operating cash flow, and high-impact regulatory risks makes this a very important filing for investors to understand the company's operational health and future outlook.
At the time of this filing, ACMR was trading at $57.80 on NASDAQ in the Technology sector, with a market capitalization of approximately $3.7B. The 52-week trading range was $16.82 to $71.65. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.